Valiant Organics Allots 15,000 Shares Under ESOP 2022, Boosting Paid-up Capital
Valiant Organics Ltd has announced the allotment of equity shares stemming from the exercise of stock options by an eligible employee under its 'Valiant - Employees Stock Option Plan- 2022' (ESOP 2022). The shares were allotted on June 22, 2026.The allotment relates to the utilization of ESOP 2022 and involves the issuance of 15,000 equity shares, each having a face value of Rs. 10/-.
Details pertaining to the share allotment are as follows:
| Employee Stock Option Scheme | Number of Shares Allotted | Exercise / Issue Price (in Rs.) |
|---|---|---|
| Valiant - Employees Stock Option Plan- 2022 | 15,000 | 10 |
| Total | 15,000 | 1,50,000 |
The infusion of these new shares has resulted in an increase in the company's paid-up equity share capital. Previously, the paid-up equity stood at Rs. 28,01,96,100, representing 2,80,19,610 fully paid-up equity shares of face value of Rs. 10/- each. Following the allotment, the paid-up equity share capital of Valiant Organics Ltd has increased to Rs. 28,03,46,100, representing 2,80,34,610 fully paid-up equity shares of face value of Rs. 10/- each.
The newly issued Equity Shares are stated to rank pari-passu in all respects with the company's existing Equity Shares.
VALIANTORG Stock Price Movement
Today, Valiant Organics Limited shed 1.01% in post-market trading, settling at ₹284.45 as investors reacted to recent market movements. The stock traded between a day high of ₹297 and a low of ₹282, with the total volume registering 28,534 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.